Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Calcium Channel Blocker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Global Calcium Channel Blocker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Industry: Pharma & Healthcare

Published Date: 2025-03-28

Pages: 139 Pages

Report ld: 4669851

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Calcium Channel Blocker Market Size(US$)

CAGR 2025-2031

1.6%

Market Size,2031

USD 88.7

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 80.6 million

Market Forecast in 2031(Value)

US$ 88.7 million

CAGR

1.6%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

In 2024, the global market size of Calcium Channel Blocker was estimated to be worth US$ 79.5 million and is forecast to reach approximately US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.

Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.

Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.

North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.

In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Calcium Channel Blocker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Calcium Channel Blocker.

The Calcium Channel Blocker market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Calcium Channel Blocker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Calcium Channel Blocker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

By Company

Pfizer

Aventis

Searle

Bayer

AstraZeneca

Knoll Pharmaceuticals

Wyeth-Ayerst

AstraZeneca

Novartis

Sanofi

Segment by Type

Dihydropyridine

Diltiazem

Verapamil

Others

Segment by Application

Hypertension

Coronary Artery Disease

Arrhythmia

Cardiomyopathy

By Region

North America

United States

Canada

Asia-Pacific

China

Japan

South Korea

India

Southeast Asia

Australia

Rest of Asia-Pacific

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Rest of Europe

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Calcium Channel Blocker in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 3: Detailed analysis of Calcium Channel Blocker manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Calcium Channel Blocker sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Calcium Channel Blocker Product Introduction

1.2 Market by Type

1.2.1 Global Calcium Channel Blocker Market Size Growth Rate by Type (2020 VS 2024 VS 2031)

1.2.2 Dihydropyridine

1.2.3 Diltiazem

1.2.4 Verapamil

1.2.5 Others

1.3 Market by Application

1.3.1 Global Calcium Channel Blocker Market Size Growth Rate by Application (2020 VS 2024 VS 2031)

1.3.2 Hypertension

1.3.3 Coronary Artery Disease

1.3.4 Arrhythmia

1.3.5 Cardiomyopathy

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Calcium Channel Blocker Market Size Estimates and Forecasts

2.1.1 Global Calcium Channel Blocker Revenue 2020-2031

2.1.2 Global Calcium Channel Blocker Sales 2020-2031

2.2 Calcium Channel Blocker Market Size by Region: 2024 Versus 2031

2.3 Calcium Channel Blocker Sales by Region (2020-2031)

2.3.1 Global Calcium Channel Blocker Sales by Region: 2020-2025

2.3.2 Global Calcium Channel Blocker Sales Forecast by Region (2026-2031)

2.3.3 Global Calcium Channel Blocker Sales Market Share by Region (2020-2031)

2.4 Calcium Channel Blocker Market Estimates and Projections by Region (2026-2031)

2.4.1 Global Calcium Channel Blocker Revenue by Region: 2020-2025

2.4.2 Global Calcium Channel Blocker Revenue Forecast by Region (2026-2031)

2.4.3 Global Calcium Channel Blocker Revenue Market Share by Region (2020-2031)

3 Market Segments

3.1 Breakdown Data by Type

3.1.1 Global Calcium Channel Blocker Sales by Type (2020-2031)

3.1.1.1 Global Calcium Channel Blocker Sales Volume by Type (2020-2031)

3.1.1.2 Global Calcium Channel Blocker Sales Market Share by Type (2020-2031)

3.1.2 Global Calcium Channel Blocker Revenue by Type (2020-2031)

3.1.2.1 Global Calcium Channel Blocker Revenue by Type (2020-2031)

3.1.2.2 Global Calcium Channel Blocker Revenue Market Share by Type (2020-2031)

3.1.3 Calcium Channel Blocker Average Selling Price (ASP) by Type (2020-2031)

3.2 Breakdown Data by Application

3.2.1 Global Calcium Channel Blocker Sales by Application (2020-2031)

3.2.1.1 Global Calcium Channel Blocker Sales Volume by Application (2020-2031)

3.2.1.2 Global Calcium Channel Blocker Sales Market Share by Application (2020-2031)

3.2.2 Global Calcium Channel Blocker Revenue by Application (2020-2031)

3.2.2.1 Global Calcium Channel Blocker Revenue by Application (2020-2031)

3.2.2.2 Global Calcium Channel Blocker Revenue Market Share by Application (2020-2031)

3.2.3 Calcium Channel Blocker Average Selling Price (ASP) by Application (2020-2031)

3.3 by Type and by Application Crossing Analysis

3.3.1 Dihydropyridine of Calcium Channel Blocker Revenue Market Share by Application

3.3.2 Diltiazem of Calcium Channel Blocker Revenue Market Share by Application

3.3.3 Verapamil of Calcium Channel Blocker Revenue Market Share by Application

3.3.4 Others of Calcium Channel Blocker Revenue Market Share by Application

4 Global Calcium Channel Blocker by Manufacturers

4.1 Global Top Calcium Channel Blocker Manufacturers by Sales (2020-2025)

4.1.1 Global Calcium Channel Blocker Sales by Manufacturer (2020-2025)

4.1.2 Global Calcium Channel Blocker Sales Market Share by Manufacturer (2020-2025)

4.2 Global Top Calcium Channel Blocker Manufacturers by Revenue (2020-2025)

4.2.1 Global Calcium Channel Blocker Revenue by Manufacturer (2020-2025)

4.2.2 Global Calcium Channel Blocker Revenue Share by Manufacturer (2020-2025)

4.3 Global Calcium Channel Blocker Price by Manufacturer (2020-2025)

4.4 Competitive Landscape

4.4.1 Key Calcium Channel Blocker Manufacturers Covered: Ranking by Revenue

4.4.2 Global Calcium Channel Blocker Market Concentration Ratio (CR5 and HHI) & (2020-2025)

4.4.3 Global Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.5 Global Calcium Channel Blocker Manufacturing Base Distribution, Product Type

4.5.1 Calcium Channel Blocker Manufacturers Manufacturing Base Distribution, Headquarters

4.5.2 Date of International Manufacturers Enter into Calcium Channel Blocker Market

4.5.3 Manufacturers Calcium Channel Blocker Product Type and Application

4.5.4 Dihydropyridine Market Sales of Calcium Channel Blocker by Manufacturer

4.5.5 Diltiazem Market Sales of Calcium Channel Blocker by Manufacturer

4.5.6 Verapamil Market Sales of Calcium Channel Blocker by Manufacturer

4.5.7 Others Market Sales of Calcium Channel Blocker by Manufacturer

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

5 Company Profiles

5.1 Pfizer

5.1.1 Pfizer Company Information

5.1.2 Pfizer Description, Business Overview

5.1.3 Pfizer Calcium Channel Blocker Products Offered

5.1.4 Pfizer Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.1.5 Pfizer Calcium Channel Blocker Sales by Product in 2024

5.1.6 Pfizer Calcium Channel Blocker Sales by Application in 2024

5.1.7 Pfizer Calcium Channel Blocker Sales by Geographic Area in 2024

5.1.8 Pfizer Recent Developments

5.2 Aventis

5.2.1 Aventis Company Information

5.2.2 Aventis Description, Business Overview

5.2.3 Aventis Calcium Channel Blocker Products Offered

5.2.4 Aventis Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.2.5 Aventis Calcium Channel Blocker Sales by Product in 2024

5.2.6 Aventis Calcium Channel Blocker Sales by Application in 2024

5.2.7 Aventis Calcium Channel Blocker Sales by Geographic Area in 2024

5.2.8 Aventis Recent Developments

5.3 Searle

5.3.1 Searle Company Information

5.3.2 Searle Description, Business Overview

5.3.3 Searle Calcium Channel Blocker Products Offered

5.3.4 Searle Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.3.5 Searle Calcium Channel Blocker Sales by Product in 2024

5.3.6 Searle Calcium Channel Blocker Sales by Application in 2024

5.3.7 Searle Calcium Channel Blocker Sales by Geographic Area in 2024

5.3.8 Searle Recent Developments

5.4 Bayer

5.4.1 Bayer Company Information

5.4.2 Bayer Description, Business Overview

5.4.3 Bayer Calcium Channel Blocker Products Offered

5.4.4 Bayer Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.4.5 Bayer Calcium Channel Blocker Sales by Product in 2024

5.4.6 Bayer Calcium Channel Blocker Sales by Application in 2024

5.4.7 Bayer Calcium Channel Blocker Sales by Geographic Area in 2024

5.4.8 Bayer Recent Developments

5.5 AstraZeneca

5.5.1 AstraZeneca Company Information

5.5.2 AstraZeneca Description, Business Overview

5.5.3 AstraZeneca Calcium Channel Blocker Products Offered

5.5.4 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.5.5 AstraZeneca Calcium Channel Blocker Sales by Product in 2024

5.5.6 AstraZeneca Calcium Channel Blocker Sales by Application in 2024

5.5.7 AstraZeneca Calcium Channel Blocker Sales by Geographic Area in 2024

5.5.8 AstraZeneca Recent Developments

5.6 Knoll Pharmaceuticals

5.6.1 Knoll Pharmaceuticals Company Information

5.6.2 Knoll Pharmaceuticals Description, Business Overview

5.6.3 Knoll Pharmaceuticals Calcium Channel Blocker Products Offered

5.6.4 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.6.5 Knoll Pharmaceuticals Calcium Channel Blocker Sales by Product in 2024

5.6.6 Knoll Pharmaceuticals Calcium Channel Blocker Sales by Application in 2024

5.6.7 Knoll Pharmaceuticals Calcium Channel Blocker Sales by Geographic Area in 2024

5.6.8 Knoll Pharmaceuticals Recent Developments

5.7 Wyeth-Ayerst

5.7.1 Wyeth-Ayerst Company Information

5.7.2 Wyeth-Ayerst Description, Business Overview

5.7.3 Wyeth-Ayerst Calcium Channel Blocker Products Offered

5.7.4 Wyeth-Ayerst Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.7.5 Wyeth-Ayerst Calcium Channel Blocker Sales by Product in 2024

5.7.6 Wyeth-Ayerst Calcium Channel Blocker Sales by Application in 2024

5.7.7 Wyeth-Ayerst Calcium Channel Blocker Sales by Geographic Area in 2024

5.7.8 Wyeth-Ayerst Recent Developments

5.8 AstraZeneca

5.8.1 AstraZeneca Company Information

5.8.2 AstraZeneca Description, Business Overview

5.8.3 AstraZeneca Calcium Channel Blocker Products Offered

5.8.4 AstraZeneca Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.8.5 AstraZeneca Calcium Channel Blocker Sales by Product in 2024

5.8.6 AstraZeneca Calcium Channel Blocker Sales by Application in 2024

5.8.7 AstraZeneca Calcium Channel Blocker Sales by Geographic Area in 2024

5.8.8 AstraZeneca Recent Developments

5.9 Novartis

5.9.1 Novartis Company Information

5.9.2 Novartis Description, Business Overview

5.9.3 Novartis Calcium Channel Blocker Products Offered

5.9.4 Novartis Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.9.5 Novartis Calcium Channel Blocker Sales by Product in 2024

5.9.6 Novartis Calcium Channel Blocker Sales by Application in 2024

5.9.7 Novartis Calcium Channel Blocker Sales by Geographic Area in 2024

5.9.8 Novartis Recent Developments

5.10 Sanofi

5.10.1 Sanofi Company Information

5.10.2 Sanofi Description, Business Overview

5.10.3 Sanofi Calcium Channel Blocker Products Offered

5.10.4 Sanofi Calcium Channel Blocker Sales, Revenue and Gross Margin (2020-2025)

5.10.5 Sanofi Calcium Channel Blocker Sales by Product in 2024

5.10.6 Sanofi Calcium Channel Blocker Sales by Application in 2024

5.10.7 Sanofi Calcium Channel Blocker Sales by Geographic Area in 2024

5.10.8 Sanofi Recent Developments

6 North America

6.1 North America Calcium Channel Blocker Market Size YoY Growth 2020-2031

6.2 North America Calcium Channel Blocker Market Facts & Figures by Country

6.2.1 North America Calcium Channel Blocker Sales by Country (2020-2031)

6.2.2 North America Calcium Channel Blocker Revenue by Country (2020-2031)

6.3 North America Calcium Channel Blocker Sales by Type (2020-2025)

6.4 North America Calcium Channel Blocker Sales by Application (2020-2025)

7 Asia-Pacific

7.1 Asia-Pacific Calcium Channel Blocker Market Size YoY Growth 2020-2031

7.2 Asia-Pacific Calcium Channel Blocker Market Facts & Figures by Region

7.2.1 Asia-Pacific Calcium Channel Blocker Sales by Region (2020-2031)

7.2.2 Asia-Pacific Calcium Channel Blocker Revenue by Region (2020-2031)

7.3 Asia-Pacific Calcium Channel Blocker Sales by Type (2020-2025)

7.4 Asia-Pacific Calcium Channel Blocker Sales by Application (2020-2025)

8 Europe

8.1 Europe Calcium Channel Blocker Market Size YoY Growth 2020-2031

8.2 Europe Calcium Channel Blocker Market Facts & Figures by Country

8.2.1 Europe Calcium Channel Blocker Sales by Country (2020-2031)

8.2.2 Europe Calcium Channel Blocker Revenue by Country (2020-2031)

8.3 Europe Calcium Channel Blocker Sales by Type (2020-2025)

8.4 Europe Calcium Channel Blocker Sales by Application (2020-2025)

9 Latin America

9.1 Latin America Calcium Channel Blocker Market Size YoY Growth 2020-2031

9.2 Latin America Calcium Channel Blocker Market Facts & Figures by Country

9.2.1 Latin America Calcium Channel Blocker Sales by Country (2020-2031)

9.2.2 Latin America Calcium Channel Blocker Revenue by Country (2020-2031)

9.3 Latin America Calcium Channel Blocker Sales by Type (2020-2025)

9.4 Latin America Calcium Channel Blocker Sales by Application (2020-2025)

10 Middle East and Africa

10.1 Latin America Calcium Channel Blocker Market Size YoY Growth 2020-2031

10.2 Middle East and Africa Calcium Channel Blocker Market Facts & Figures by Country

10.2.1 Middle East and Africa Calcium Channel Blocker Sales by Country (2020-2031)

10.2.2 Middle East and Africa Calcium Channel Blocker Revenue by Country (2020-2031)

10.3 Middle East and Africa Calcium Channel Blocker Sales by Type (2020-2025)

10.4 Middle East and Africa Calcium Channel Blocker Sales by Application (2020-2025)

11 Supply Chain and Sales Channel analysis

11.1 Calcium Channel Blocker Supply Chain Analysis

11.2 Calcium Channel Blocker Key Raw Materials and Upstream Suppliers

11.3 Calcium Channel Blocker Clients Analysis

11.4 Calcium Channel Blocker Sales Channel and Sales Model Analysis

11.4.1 Calcium Channel Blocker Distribution Channel Analysis: Indirect Sales VS Direct Sales

11.4.2 Calcium Channel Blocker Distribution Channel Analysis: Online Sales VS Offline Sales

11.4.3 Calcium Channel Blocker Distributors

12 Calcium Channel Blocker Market Dynamics

12.1 Calcium Channel Blocker Industry Trends

12.2 Calcium Channel Blocker Market Drivers

12.3 Calcium Channel Blocker Market Challenges

12.4 Calcium Channel Blocker Market Restraints

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.1.1 Research Programs/Design

14.1.1.2 Market Size Estimation

14.1.1.3 Market Breakdown and Data Triangulation

14.1.2 Data Source

14.1.2.1 Secondary Sources

14.1.2.2 Primary Sources

14.2 Author Details

14.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Calcium Channel Blocker Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Calcium Channel Blocker Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Calcium Channel Blocker Market Size by Region (US$ Million): 2024 VS 2031

Table 4. Global Calcium Channel Blocker Sales by Region (2020-2025) & (Kg)

Table 5. Global Calcium Channel Blocker Sales Forecast by Region (2026-2031) & (Kg)

Table 6. Global Calcium Channel Blocker Revenue by Region (2020-2025) & (US$ Million)

Table 7. Global Calcium Channel Blocker Revenue Forecast by Region (2026-2031) & (US$ Million)

Table 8. Global Calcium Channel Blocker Sales Volume by Type (2020-2025) & (Kg)

Table 9. Global Calcium Channel Blocker Sales Volume by Type (2026-2031) & (Kg)

Table 10. Global Calcium Channel Blocker Revenue by Type (2020-2025) & (US$ Million)

Table 11. Global Calcium Channel Blocker Revenue Forecast by Type (2026-2031) & (US$ Million)

Table 12. Global Calcium Channel Blocker Sales Volume by Application (2020-2025) & (Kg)

Table 13. Global Calcium Channel Blocker Sales Volume by Application (2026-2031) & (Kg)

Table 14. Global Calcium Channel Blocker Revenue by Application (2020-2025) & (US$ Million)

Table 15. Global Calcium Channel Blocker Revenue by Application (2026-2031) & (US$ Million)

Table 16. Global Calcium Channel Blocker Sales by Manufacturer (2020-2025) & (Kg)

Table 17. Global Calcium Channel Blocker Sales Share by Manufacturer (2020-2025)

Table 18. Calcium Channel Blocker Revenue by Manufacturer (2020-2025) & (US$ Million)

Table 19. Calcium Channel Blocker Revenue Share by Manufacturer (2020-2025)

Table 20. Key Manufacturers Calcium Channel Blocker Price (2020-2025) & (USD/g)

Table 21. Ranking of Global Top Calcium Channel Blocker Manufacturers by Revenue (US$ Million) in 2024

Table 22. Global Calcium Channel Blocker Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)

Table 23. Global Calcium Channel Blocker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcium Channel Blocker as of 2024)

Table 24. Calcium Channel Blocker Manufacturers Manufacturing Base Distribution and Headquarters

Table 25. Date of International Manufacturers Enter into Calcium Channel Blocker Market

Table 26. Manufacturers Calcium Channel Blocker Product Type and Application

Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 28. Pfizer Company Information

Table 29. Pfizer Description and Business Overview

Table 30. Pfizer Calcium Channel Blocker Product

Table 31. Pfizer Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 32. Pfizer Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 33. Pfizer Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 34. Pfizer Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 35. Pfizer Recent Developments

Table 36. Aventis Company Information

Table 37. Aventis Description and Business Overview

Table 38. Aventis Calcium Channel Blocker Product

Table 39. Aventis Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 40. Aventis Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 41. Aventis Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 42. Aventis Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 43. Aventis Recent Developments

Table 44. Searle Company Information

Table 45. Searle Description and Business Overview

Table 46. Searle Calcium Channel Blocker Product

Table 47. Searle Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 48. Searle Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 49. Searle Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 50. Searle Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 51. Searle Recent Developments

Table 52. Bayer Company Information

Table 53. Bayer Description and Business Overview

Table 54. Bayer Calcium Channel Blocker Product

Table 55. Bayer Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 56. Bayer Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 57. Bayer Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 58. Bayer Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 59. Bayer Recent Developments

Table 60. AstraZeneca Company Information

Table 61. AstraZeneca Description and Business Overview

Table 62. AstraZeneca Calcium Channel Blocker Product

Table 63. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 64. AstraZeneca Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 65. AstraZeneca Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 66. AstraZeneca Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 67. AstraZeneca Recent Developments

Table 68. Knoll Pharmaceuticals Company Information

Table 69. Knoll Pharmaceuticals Description and Business Overview

Table 70. Knoll Pharmaceuticals Calcium Channel Blocker Product

Table 71. Knoll Pharmaceuticals Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 72. Knoll Pharmaceuticals Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 73. Knoll Pharmaceuticals Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 74. Knoll Pharmaceuticals Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 75. Knoll Pharmaceuticals Recent Developments

Table 76. Wyeth-Ayerst Company Information

Table 77. Wyeth-Ayerst Description and Business Overview

Table 78. Wyeth-Ayerst Calcium Channel Blocker Product

Table 79. Wyeth-Ayerst Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 80. Wyeth-Ayerst Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 81. Wyeth-Ayerst Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 82. Wyeth-Ayerst Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 83. Wyeth-Ayerst Recent Developments

Table 84. AstraZeneca Company Information

Table 85. AstraZeneca Description and Business Overview

Table 86. AstraZeneca Calcium Channel Blocker Product

Table 87. AstraZeneca Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 88. AstraZeneca Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 89. AstraZeneca Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 90. AstraZeneca Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 91. AstraZeneca Recent Developments

Table 92. Novartis Company Information

Table 93. Novartis Description and Business Overview

Table 94. Novartis Calcium Channel Blocker Product

Table 95. Novartis Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 96. Novartis Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 97. Novartis Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 98. Novartis Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 99. Novartis Recent Developments

Table 100. Sanofi Company Information

Table 101. Sanofi Description and Business Overview

Table 102. Sanofi Calcium Channel Blocker Product

Table 103. Sanofi Calcium Channel Blocker Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2020-2025)

Table 104. Sanofi Sales Proportion of Calcium Channel Blocker by Product in 2024

Table 105. Sanofi Sales Proportion of Calcium Channel Blocker by Application in 2024

Table 106. Sanofi Sales Proportion of Calcium Channel Blocker by Geographic Area in 2024

Table 107. Sanofi Recent Developments

Table 108. North America Calcium Channel Blocker Sales by Country (2020-2025) & (Kg)

Table 109. North America Calcium Channel Blocker Sales by Country (2026-2031) & (Kg)

Table 110. North America Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)

Table 111. North America Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)

Table 112. North America Calcium Channel Blocker Sales by Type (2020-2025) & (Kg)

Table 113. North America Calcium Channel Blocker Sales by Application (2020-2025) & (Kg)

Table 114. Asia-Pacific Calcium Channel Blocker Sales by Region (2020-2025) & (Kg)

Table 115. Asia-Pacific Calcium Channel Blocker Sales by Region (2026-2031) & (Kg)

Table 116. Asia-Pacific Calcium Channel Blocker Revenue by Region (2020-2025) & (US$ Million)

Table 117. Asia-Pacific Calcium Channel Blocker Revenue by Region (2026-2031) & (US$ Million)

Table 118. Asia-Pacific Calcium Channel Blocker Sales by Type (2020-2025) & (Kg)

Table 119. Asia-Pacific Calcium Channel Blocker Sales by Application (2020-2025) & (Kg)

Table 120. Europe Calcium Channel Blocker Sales by Country (2020-2025) & (Kg)

Table 121. Europe Calcium Channel Blocker Sales by Country (2026-2031) & (Kg)

Table 122. Europe Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)

Table 123. Europe Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)

Table 124. Europe Calcium Channel Blocker Sales by Type (2020-2025) & (Kg)

Table 125. Europe Calcium Channel Blocker Sales by Application (2020-2025) & (Kg)

Table 126. Latin America Calcium Channel Blocker Sales by Country (2020-2025) & (Kg)

Table 127. Latin America Calcium Channel Blocker Sales by Country (2026-2031) & (Kg)

Table 128. Latin America Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)

Table 129. Latin America Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)

Table 130. Latin America Calcium Channel Blocker Sales by Type (2020-2025) & (Kg)

Table 131. Latin America Calcium Channel Blocker Sales by Application (2020-2025) & (Kg)

Table 132. Middle East and Africa Calcium Channel Blocker Sales by Country (2020-2025) & (Kg)

Table 133. Middle East and Africa Calcium Channel Blocker Sales by Country (2026-2031) & (Kg)

Table 134. Middle East and Africa Calcium Channel Blocker Revenue by Country (2020-2025) & (US$ Million)

Table 135. Middle East and Africa Calcium Channel Blocker Revenue by Country (2026-2031) & (US$ Million)

Table 136. Middle East and Africa Calcium Channel Blocker Sales by Type (2020-2025) & (Kg)

Table 137. Middle East and Africa Calcium Channel Blocker Sales by Application (2020-2025) & (Kg)

Table 138. Calcium Channel Blocker Key Raw Materials, Industry Status and Trend

Table 139. Calcium Channel Blocker Key Raw Materials and Upstream Suppliers

Table 140. Calcium Channel Blocker Clients Status and Trend

Table 141. Calcium Channel Blocker Typical Clients

Table 142. Calcium Channel Blocker Distributors

Table 143. Calcium Channel Blocker Market Trends

Table 144. Calcium Channel Blocker Market Drivers

Table 145. Calcium Channel Blocker Market Challenges

Table 146. Calcium Channel Blocker Market Restraints

Table 147. Research Programs/Design for This Report

Table 148. Key Data Information from Secondary Sources

Table 149. Key Data Information from Primary Sources

Table 150. QYR Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. Calcium Channel Blocker Product Picture

Figure 2. Global Calcium Channel Blocker Market Size by Type (US$ Million): 2020 VS 2024 VS 2031

Figure 3. Global Calcium Channel Blocker Sales Market Share by Type in 2024 & 2031

Figure 4. Dihydropyridine Product Picture

Figure 5. Diltiazem Product Picture

Figure 6. Verapamil Product Picture

Figure 7. Others Product Picture

Figure 8. Global Calcium Channel Blocker Market Size by Application (US$ Million): 2020 VS 2024 VS 2031

Figure 9. Global Calcium Channel Blocker Sales Market Share by Application in 2024 & 2031

Figure 10. Hypertension

Figure 11. Coronary Artery Disease

Figure 12. Arrhythmia

Figure 13. Cardiomyopathy

Figure 14. Calcium Channel Blocker Report Years Considered

Figure 15. Global Calcium Channel Blocker Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Calcium Channel Blocker Market Size 2020-2031 (US$ Million)

Figure 17. Global Calcium Channel Blocker Sales 2020-2031 (Kg)

Figure 18. Global Calcium Channel Blocker Sales Market Share Forecast by Region (2020-2031)

Figure 19. Global Calcium Channel Blocker Revenue Market Share by Region (2020-2031)

Figure 20. Global Calcium Channel Blocker Sales Market Share Forecast by Type (2020-2031)

Figure 21. Global Calcium Channel Blocker Revenue Market Share Forecast by Type (2020-2031)

Figure 22. Calcium Channel Blocker Average Selling Price (ASP) by Type (2020-2025) & (USD/g)

Figure 23. Global Calcium Channel Blocker Sales Market Share Forecast by Application (2020-2031)

Figure 24. Global Calcium Channel Blocker Revenue Market Share Forecast by Application (2020-2031)

Figure 25. Calcium Channel Blocker Average Selling Price (ASP) by Application (2020-2025) & (USD/g)

Figure 26. Dihydropyridine of Calcium Channel Blocker Revenue Market Share by Application, 2024 VS 2031

Figure 27. Diltiazem of Calcium Channel Blocker Revenue Market Share by Application, 2024 VS 2031

Figure 28. Verapamil of Calcium Channel Blocker Revenue Market Share by Application, 2024 VS 2031

Figure 29. Others of Calcium Channel Blocker Revenue Market Share by Application, 2024 VS 2031

Figure 30. Global Calcium Channel Blocker Sales Share by Manufacturer in 2024

Figure 31. Calcium Channel Blocker Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 32. Dihydropyridine Market Sales Proportion by Manufacturer in 2024

Figure 33. Diltiazem Market Sales Proportion by Manufacturer in 2024

Figure 34. Verapamil Market Sales Proportion by Manufacturer in 2024

Figure 35. Others Market Sales Proportion by Manufacturer in 2024

Figure 36. North America Calcium Channel Blocker Revenue 2020-2031 (US$ Million)

Figure 37. North America Calcium Channel Blocker Sales Market Share by Type (2020-2025)

Figure 38. North America Calcium Channel Blocker Sales Market Share by Application (2020-2025)

Figure 39. Asia-Pacific Calcium Channel Blocker Revenue 2020-2031 (US$ Million)

Figure 40. Asia-Pacific Calcium Channel Blocker Sales Market Share by Region (2020-2031)

Figure 41. Asia-Pacific Calcium Channel Blocker Revenue Market Share by Region (2020-2031)

Figure 42. Asia-Pacific Calcium Channel Blocker Sales Market Share by Type (2020-2025)

Figure 43. Asia-Pacific Calcium Channel Blocker Sales Market Share by Application (2020-2025)

Figure 44. Europe Calcium Channel Blocker Revenue Growth Rate 2020-2031 (US$ Million)

Figure 45. Europe Calcium Channel Blocker Sales Market Share by Country (2020-2031)

Figure 46. Europe Calcium Channel Blocker Revenue Market Share by Country (2020-2031)

Figure 47. Europe Calcium Channel Blocker Sales Market Share by Type (2020-2025)

Figure 48. Europe Calcium Channel Blocker Sales Market Share by Application (2020-2025)

Figure 49. Latin America Calcium Channel Blocker Revenue Growth Rate 2020-2031 (US$ Million)

Figure 50. Latin America Calcium Channel Blocker Sales Market Share by Country (2020-2031)

Figure 51. Latin America Calcium Channel Blocker Revenue Market Share by Country (2020-2025)

Figure 52. Latin America Calcium Channel Blocker Sales Market Share by Type (2020-2025)

Figure 53. Latin America Calcium Channel Blocker Sales Market Share by Application (2020-2025)

Figure 54. Middle East and Africa Calcium Channel Blocker Revenue Growth Rate 2020-2031 (US$ Million)

Figure 55. Middle East and Africa Calcium Channel Blocker Sales Market Share by Country (2020-2031)

Figure 56. Middle East and Africa Calcium Channel Blocker Revenue Market Share by Country (2020-2031)

Figure 57. Middle East and Africa Calcium Channel Blocker Sales Market Share by Type (2020-2025)

Figure 58. Middle East and Africa Calcium Channel Blocker Sales Market Share by Application (2020-2025)

Figure 59. Calcium Channel Blocker Supply Chain (Upstream and Downstream Market)

Figure 60. Global Production Market Share of Calcium Channel Blocker Raw Materials by Region in 2024

Figure 61. Calcium Channel Blocker Distribution Channels

Figure 62. Global Calcium Channel Blocker Percentage 2020-2031: Indirect Sales VS Direct Sales

Figure 63. Global Calcium Channel Blocker Percentage 2020-2031: Online Sales VS Offline Sales

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Calcium Channel Blocker market? zhanKai

The top companies in the global Calcium Channel Blocker market are Pfizer、Aventis、Searle.

What is the annual compound growth rate of the global Calcium Channel Blocker market size from 2025 to 2031? shouQi

Which region is expected to have the highest market share? shouQi

What was the global market size of Calcium Channel Blocker in 2025? shouQi

What was the global market size of Calcium Channel Blocker in 2031? shouQi

Related Reports

Global Calcium Channel Blocker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Calcium Channel Blocker market size was US$ 80.61 million in 2025 and is forecast to reach a readjusted size of US$ 89.94 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Calcium Channel Blocker Market Research Report 2026
The global Calcium Channel Blocker market was valued at US$ 80.61 million in 2025 and is anticipated to reach US$ 89.94 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Calcium Channel Blocker- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Calcium Channel Blocker was estimated to be worth US$ 80.61 million in 2025 and is projected to reach US$ 89.94 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Calcium Channel Blocker Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Calcium Channel Blocker market is projected to grow from US$ 79.5 million in 2024 to US$ 88.7 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 143
USD 4900.00
(Single User License)
Global Calcium Channel Blocker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Calcium Channel Blocker market size was US$ 79.5 million in 2024 and is forecast to a readjusted size of US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 78
USD 4250.00
(Single User License)
Calcium Channel Blocker- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Calcium Channel Blocker was estimated to be worth US$ 79.5 million in 2024 and is forecast to a readjusted size of US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Calcium Channel Blocker Market Research Report 2025
The global market for Calcium Channel Blocker was valued at US$ 79.5 million in the year 2024 and is projected to reach a revised size of US$ 88.7 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published Date: 2025-01-16
Pages: 80
USD 2900.00
(Single User License)
Global Calcium Channel Blocker Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published Date: 2024-04-17
Pages: 153
USD 5600.00
(Single User License)
Global Calcium Channel Blocker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published Date: 2024-04-16
Pages: 147
USD 5900.00
(Single User License)
Global Calcium Channel Blocker Market Insights, Forecast to 2030
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published Date: 2024-04-07
Pages: 110
USD 4900.00
(Single User License)

Global Calcium Channel Blocker Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Calcium Channel Blocker market size was US$ 80.61 million in 2025 and is forecast to reach a readjusted size of US$ 89.94 million by 2032 with a CAGR of 1.6% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)
Global Calcium Channel Blocker Market Research Report 2026
The global Calcium Channel Blocker market was valued at US$ 80.61 million in 2025 and is anticipated to reach US$ 89.94 million by 2032, at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)
Calcium Channel Blocker- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Calcium Channel Blocker was estimated to be worth US$ 80.61 million in 2025 and is projected to reach US$ 89.94 million, growing at a CAGR of 1.6% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)
Global Calcium Channel Blocker Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Calcium Channel Blocker market is projected to grow from US$ 79.5 million in 2024 to US$ 88.7 million by 2031, at a CAGR of 1.6% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 143
USD 4900.00 (Single User License)
Global Calcium Channel Blocker Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Calcium Channel Blocker market size was US$ 79.5 million in 2024 and is forecast to a readjusted size of US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 78
USD 4250.00 (Single User License)
Calcium Channel Blocker- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Calcium Channel Blocker was estimated to be worth US$ 79.5 million in 2024 and is forecast to a readjusted size of US$ 88.7 million by 2031 with a CAGR of 1.6% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)
Global Calcium Channel Blocker Market Research Report 2025
The global market for Calcium Channel Blocker was valued at US$ 79.5 million in the year 2024 and is projected to reach a revised size of US$ 88.7 million by 2031, growing at a CAGR of 1.6% during the forecast period.
Published: 2025-01-16
Pages: 80
USD 2900.00 (Single User License)
Global Calcium Channel Blocker Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published: 2024-04-17
Pages: 153
USD 5600.00 (Single User License)
Global Calcium Channel Blocker Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published: 2024-04-16
Pages: 147
USD 5900.00 (Single User License)
Global Calcium Channel Blocker Market Insights, Forecast to 2030
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Published: 2024-04-07
Pages: 110
USD 4900.00 (Single User License)